117 results
Page 2 of 6
S-8
EX-4.5
lwfi 67i43
22 May 24
Registration of securities for employees
4:33pm
S-8
EX-4.3
i5o1 6ety2tahh
22 May 24
Registration of securities for employees
4:33pm
S-8
EX-4.6
znoxjiej
22 May 24
Registration of securities for employees
4:33pm
S-8
EX-4.2
dz6fiuoz
22 May 24
Registration of securities for employees
4:33pm
S-8
EX-4.4
liz3nyszrsje
22 May 24
Registration of securities for employees
4:33pm
8-K
EX-99.1
i31336ek
24 Apr 24
Viking Therapeutics Reports First Quarter 2024 Financial Results and Provides Corporate Update
4:05pm
424B5
yjqxcg44 e3l8b
1 Mar 24
Prospectus supplement for primary offering
4:13pm
8-K
EX-1.1
o3ombjg uk3
1 Mar 24
Viking Therapeutics Announces Pricing of $550 Million Public Offering of Common Stock
4:05pm
424B5
wkz6nt
27 Feb 24
Prospectus supplement for primary offering
5:21pm
8-K
EX-99.1
vl5 4ykkn3poa3k
7 Feb 24
Viking Therapeutics Reports Fourth Quarter and Year-End 2023 Financial Results and Provides Corporate Update
4:09pm
8-K
EX-99.1
gacssvonn9
25 Oct 23
Viking Therapeutics Reports Third Quarter 2023 Financial Results and Provides Corporate Update
4:24pm
S-3ASR
jy8j9j
26 Jul 23
Automatic shelf registration
5:26pm
S-3ASR
EX-4.2
rxg 191myhnii
26 Jul 23
Automatic shelf registration
5:26pm